Figures & Tables
Tables
- TABLE 1.
Demographic and Behavioral Characteristics of Women of Reproductive Age in Luanda, Angola, 2012
Variables Age Groups 15–19 (N=451) 20–24 (N=361) ≥25 (N=729) All (N=1545) Sociodemographics Age, median NA NA NA 24.0 Marital status Single 98.2 81.7 39.4 66.5 Married/cohabiting 1.8 18.3 56.0 31.3 Divorced/widowed 0.0 0.0 4.1 2.2 Education High school or less 55.3 28.8 45.3 44.4 More than high school 44.7 71.2 54.7 55.6 Sexual Behavior and Fertility Preferences Ever had sex 55.0 90.9 91.4 80.6 Ever been pregnant 11.5 49.9 90.4 57.9 Intention to get pregnant at last pregnancya Wanted it at that moment 17.3 27.8 57.7 49.3 Wanted it later 53.8 56.1 28.1 35.2 Did not want more children 28.8 16.1 14.3 15.5 Ideal number of children, meanb 3.8 3.7 4.3 4.2 Knowledge of modern contraceptives Condoms 96.7 95.6 93.7 95.0 Oral contraceptive pills 68.9 84.2 87.4 79.7 Injectable 47.2 65.7 84.1 68.9 Female condoms 34.2 42.1 54.7 45.6 IUD 19.1 36.3 54.2 39.6 Implants 18.2 35.7 52.7 38.6 Female sterilization 14.6 26.6 39.4 29.1 Emergency oral contraceptive pills 10.3 21.6 32.8 23.5 Male sterilization 5.3 12.5 22.2 15.0 Contraceptive Usec Current prevalence of any modern contraception 58.5 64.9 55.9 58.7 Current prevalence of: Condoms 52.0 46.0 17.7 32.1 Injectables 2.0 6.1 18.8 12.1 Oral contraceptive pills 3.2 11.0 14.1 11.1 Implants 0.4 1.5 2.6 1.9 IUD 0.0 0.0 1.4 0.7 Female sterilization 0.8 0.0 0.8 0.6 Female condoms 0.0 0.3 0.6 0.4 Male sterilization 0.0 0.0 0.0 0.0 Ever used emergency contraceptive pillsd 1.1 6.4 5.8 4.5 Current contraceptive users not using their preferred methode 15.1 20.7 16.0 17.3 Preferred contraceptive method among women not using their preferred methodf Injectables 13.6 25.0 31.0 25.6 Condom 31.8 22.7 8.6 17.6 Implants 13.6 4.6 27.6 16.8 Oral contraceptive pills 4.6 13.6 12.1 12.0 Rhythm method 4.6 0.0 1.7 1.6 Female condom 4.6 0.0 0.0 0.8 Female sterilization 0.0 0.0 1.7 0.8 None 13.6 20.5 0.0 9.6 Other 13.6 13.6 17.2 15.2 Abbreviation: IUD, intrauterine device.
All data are reported as percentages unless otherwise noted.
↵a Among women ever pregnant (N=52 among 15–19-year-olds; N=180 among 20–24-year-olds; N=659 among ≥25-year-olds; and N=891 among the entire sample of women).
↵b Among women who have given birth (N=25 among 15–19-year-olds; N=128 among 20–24-year-olds; N=608 among ≥25-year-olds; and N=764 among the entire sample of women).
↵c Among women who have had sex (N=248 among 15–19-year-olds; N=328 among 20–24-year-olds; N=666 among ≥25-year-olds; and N=1245 among the entire sample of women).
↵d The survey did not explicitly include emergency contraceptive pills as an option for current method but included a question on ever use of emergency contraceptive pills.
↵e Among fecund women who have had sex and who are currently using contraception (N=146 among 15–19-year-olds; N=213 among 20–24-year-olds; N=363 among ≥25-year-olds; and N=722 among the entire sample of women).
↵f N=22 among 15–19-year-olds; N=44 among 20–24-year-olds; N=58 among ≥25-year-olds; and N=125 among the entire sample of women.
Method Private Sector Public Sector Total 2014 (N=1782) 2015 (N=739) Difference 2014 (N=51) 2015 (N=27) Difference 2014 (N=1833) 2015 (N=766) Difference Any methoda 97.6 86.9 −10.7*** 84.3 59.3 −25.0* 97.2 85.9 −11.3*** Male condom 82.3 75.1 −7.3*** 49.0 33.3 −15.7 81.4 73.6 −7.8*** Oral contraceptive pillsb 58.7 43.8 −14.9*** 54.1 29.6 −24.5* 58.6 43.3 −15.3*** Emergency contraceptive pillsb 43.3 35.8 −7.5** 11.8 11.1 −0.7 42.4 34.4 −7.5** Injectablesb 13.1 6.6 −7.56.5*** 19.6 18.5 −1.1 13.3 7.3 −6.0*** All data for 2014 and 2015 reported as percentages; the differences between 2014 and 2015 are percentage points.
↵*P<.05;
↵** P<.01;
↵*** P<.001.
↵a Any method includes at least one of the following: condoms, oral contraceptive pills, emergency contraceptive pills, injectable methods, hormonal patches, spermicides, intrauterine devices (IUDs), mini-mola or Essure (a non-surgical permanent method for women), and Vasalgel (a long-acting gel similar to no-scalpel vasectomy but likely more reversible). Less than 5% of the outlets overall reported having hormonal patches, female condoms, spermicides, IUDs, vaginal rings, or implants. Only 0.1% reported providing mini-mola or Essure or Vasalgel.
↵b Gas stations, hotels, and bars were not included in the calculation of oral contraceptive pills, emergency contraceptive pills, or injectable availability, since those outlets mainly distribute or sell condoms.
- TABLE 3.
Brand Market Share by Type of Contraceptive Among Outlets Selling the Respective Contraceptive Method, Luanda, Angola, 2015
Contraceptive Method and Brand % Outlets Offering the Brand Units Sold Last Montha % Units Value (AKZ) Sold
Last Month% Value Condoms (N=635 outlets) Sensual 51.8 17,716 22.8 1,295,650 25.6 Legal 37.3 17,092 22.0 845,000 16.7 Davigra 15.6 12,103 15.6 535,530 10.6 Boss Man 11.8 3,153 4.1 176,240 3.5 Kamasutra 9.6 2,193 2.8 6,300 0.1 Control 6.0 4,711 6.1 611,994 12.1 Durex 3.3 8,576 11.0 948,365 18.7 Generic 1.3 7,527 9.7 293,150 5.8 Other brands (+40) <5.0 each 4,557 5.9 358,795 7.1 Total for condoms NA 77,628 100.0 5,071,024 100.0 Oral contraceptive pills (N=357 outlets) Microgynon 76.6 2,885 66.0 1,058,303 40.6 Microlut 27.7 457 10.4 141,394 5.4 Yasmin 8.6 234 5.3 434,366 16.4 Diane 35 7.8 108 2.5 167,442 6.4 Other brands (+10)b <5.0 each 690 15.8 802,642 31.2 Total for oral contraceptive pills NA 4,374 100.0 2,604,147 100.0 Emergency contraceptive pills (N=255 outlets) Pilula S 45.4 1,064 38.4 656,100 22.7 Ella 24.3 595 21.5 554,200 19.1 IPL72 20.4 463 16.7 330,700 11.4 Norlevo 14.1 6 0.2 1,086,707 37.5 Other brands (7)c <5.0 each 643 23.2 266,518 9.3 Total for emergency contraceptive pills NA 2,771 100.0 2,894,225 100.0 Injectables (N=54 outlets) Depo-provera 83.3 260 97.7 21,700 94.1 Mesignya 1.9 n/a n/a n/a n/a Other brands <1.0 each 6 2.3 1,360 5.9 Total for injectables NA 266 100.0 23,060 100.0 Abbreviation: AKZ, Angolan Kwanzas.
↵a Units are individual condoms for condoms; cycles for oral contraceptive pills; packs for emergency contraceptive pills; and individual units for injectables.
↵b Other brands of oral contraceptive pills included Cezarette, Climen, Ella, Gynera, Marvelon, Minygesty, etc.
↵c Other brands of emergency contraceptive pills included CO-Pill, Plan Fam, Levo 72, etc.
- TABLE 4.
Mean Price (Angolan Kwanzas)a for Main Brands of Contraceptives, Luanda, Angola, 2014–2015
Method and Brand [No. of outlets selling the method in 2014, 2015] Mean Price per Unitb (95% CI) % Change 2014 2015 Condoms Sensual [N=697; N=359] 69.5 (44.3, 72.7) 73.4 (71.2, 75.6) +5.6% Legal [N=529; N=237] 36.1 (33.2, 39.0) 46.8 (42.8, 50.8) +29.8%̂ Davigra [N=267; N=99] 59.5 (55.5, 63.5) 58.9 (45.0, 72.7) −1.0% Durex [N=57; N=21] 119.3 (90.8, 147.8) 200.9 (145.1, 256.8) +68.4% Boss Man [N=264; N=71] 54.1 (51.2, 57.0) 60.4 (55.7, 65.2) +11.7% Oral contraceptive pills Microgynon [N=840; N=261] 238.8 (231.7, 245.9) 498.5 (448.3, 548.8) +108.8%̂ Microlut [N=365; N=82] 278.8 (264.5, 293.2) 394.8 (346.0, 443.6) +41.6%̂ Yasmin [N=51; N=43] 705.5 (651.8, 759.3) 2300.2 (2017.5, 2583.0) +226.0%̂ Diane 35 [N=69; N=22] 1068.5 (952.9, 1184.0) 1830.7 (1200.3, 2461.1) +71.3%̂ Emergency contraceptive pills Pilula S [N=325; N=108] 453.4 (427.3, 479.5) 579.2 (536.0, 622.4) +27.7%̂ Ella [N=225; N=63] 699.3 (657.5, 741.1) 959.0 (659.5, 1258.6) +37.1%̂ IPL72 [N=113; N=46] 509.6 (456.0, 563.3) 700.5 (602.8, 798.2) +37.5%̂ Norlevo [N=109; N=30] 2026.9 (1814.3, 2239.4) 2950.9 (2502.3, 3399.6) +45.6%^ Injectables Depo-provera [N=213; N=45] 351.0 (321.0, 281.1) 482.2 (323.0, 641.5) +37.4%^ ̂ Indicates significant changes based on 95% confidence intervals not overlapping between 2014 and 2015.
↵a Prices reflect mostly the private sector. According to the National Health Care System, the public sector must offer health services and medicines for free. The exchange rate as of October 30, 2014, was 99 Angolan Kwanzas for US$1.26
↵b Units are individual condoms for condoms; cycles for oral contraceptive pills; packs for emergency contraceptive pills; and individual units for injectables.
In this issue
